Abstract
After the revolution which was brought with the introduction of operationalized diagnostic criteria by contemporary classification systems, the reliability and the validity of psychiatric diagnosis were greatly improved. Following the improvement in categorical diagnosis, two new needs emerge. The first is to explore all aspects of symptomatology and quantify severity. This is a function addressed with the use of psychometric and neuropsychological tools. There is much improvement in this field although much remains to be done (see Chap. 14). The second and still unfulfilled need is to define and rate seriousness, progression, changes in physiology and damage made and the extent and the specific characteristics of the disease. ‘Staging’ is the term which defines this procedure and it can provide the clinician with a valuable tool to assist the treatment design.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Alessandra MA, Colom F, Pacchiarotti I, Murru A, Scott J, Valenti M, Mazzarini L, Mar Bonnin CD, Jose SM, Serretti A, Vieta E (2013) Treatment strategies according to clinical features in a naturalistic cohort study of bipolar patients: a principal component analysis of lifetime pharmacological and biophysic treatment options. Eur Neuropsychopharmacol 23(4):263–275
Andreazza AC, Cassini C, Rosa AR, Leite MC, de Almeida LM, Nardin P, Cunha AB, Cereser KM, Santin A, Gottfried C, Salvador M, Kapczinski F, Goncalves CA (2007a) Serum S100B and antioxidant enzymes in bipolar patients. J Psychiatr Res 41(6):523–529. doi:10.1016/j.jpsychires.2006.07.013
Andreazza AC, Frey BN, Erdtmann B, Salvador M, Rombaldi F, Santin A, Goncalves CA, Kapczinski F (2007b) DNA damage in bipolar disorder. Psychiatry Res 153(1):27–32. doi:10.1016/j.psychres.2006.03.025
Andreazza AC, Kapczinski F, Kauer-Sant’Anna M, Walz JC, Bond DJ, Goncalves CA, Young LT, Yatham LN (2009) 3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. J Psychiatry Neurosci 34(4):263–271
Arango C, Rapado-Castro M, Reig S, Castro-Fornieles J, Gonzalez-Pinto A, Otero S, Baeza I, Moreno C, Graell M, Janssen J, Parellada M, Moreno D, Bargallo N, Desco M (2012) Progressive brain changes in children and adolescents with first-episode psychosis. Arch Gen Psychiatry 69(1):16–26. doi:10.1001/archgenpsychiatry.2011.150
Aronson TA, Shukla S, Gujavarty K, Hoff A, DiBuono M, Khan E (1988a) Relapse in delusional depression: a retrospective study of the course of treatment. Compr Psychiatry 29(1):12–21
Aronson TA, Shukla S, Hoff A, Cook B (1988b) Proposed delusional depression subtypes: preliminary evidence from a retrospective study of phenomenology and treatment course. J Affect Disord 14(1):69–74
Bai YM, Su TP, Tsai SJ, Wen-Fei C, Li CT, Pei-Chi T, Mu-Hong C (2014) Comparison of inflammatory cytokine levels among type I/type II and manic/hypomanic/euthymic/depressive states of bipolar disorder. J Affect Disord 166:187–192. doi:10.1016/j.jad.2014.05.009
Balanza-Martinez V, Tabares-Seisdedos R, Selva-Vera G, Martinez-Aran A, Torrent C, Salazar-Fraile J, Leal-Cercos C, Vieta E, Gomez-Beneyto M (2005) Persistent cognitive dysfunctions in bipolar I disorder and schizophrenic patients: a 3-year follow-up study. Psychother Psychosom 74(2):113–119. doi:10.1159/000083170
Baldessarini RJ, Tondo L, Visioli C (2014) First-episode types in bipolar disorder: predictive associations with later illness. Acta Psychiatr Scand 129(5):383–392. doi:10.1111/acps.12204
Berk M (2009) Neuroprogression: pathways to progressive brain changes in bipolar disorder. Int J Neuropsychopharmacol 12(4):441–445. doi:10.1017/S1461145708009498
Berk M, Conus P, Lucas N, Hallam K, Malhi GS, Dodd S, Yatham LN, Yung A, McGorry P (2007a) Setting the stage: from prodrome to treatment resistance in bipolar disorder. Bipolar Disord 9(7):671–678. doi:10.1111/j.1399-5618.2007.00484.x
Berk M, Hallam KT, McGorry PD (2007b) The potential utility of a staging model as a course specifier: a bipolar disorder perspective. J Affect Disord 100(1–3):279–281. doi:10.1016/j.jad.2007.03.007
Berk M, Copolov DL, Dean O, Lu K, Jeavons S, Schapkaitz I, Anderson-Hunt M, Bush AI (2008) N-acetyl cysteine for depressive symptoms in bipolar disorder–a double-blind randomized placebo-controlled trial. Biol Psychiatry 64(6):468–475. doi:10.1016/j.biopsych.2008.04.022
Berk M, Hallam K, Malhi GS, Henry L, Hasty M, Macneil C, Yucel M, Pantelis C, Murphy B, Vieta E, Dodd S, McGorry PD (2010) Evidence and implications for early intervention in bipolar disorder. J Ment Health 19(2):113–126. doi:10.3109/09638230903469111
Berk M, Brnabic A, Dodd S, Kelin K, Tohen M, Malhi GS, Berk L, Conus P, McGorry PD (2011a) Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention. Bipolar Disord 13(1):87–98. doi:10.1111/j.1399-5618.2011.00889.x
Berk M, Kapczinski F, Andreazza AC, Dean OM, Giorlando F, Maes M, Yucel M, Gama CS, Dodd S, Dean B, Magalhaes PV, Amminger P, McGorry P, Malhi GS (2011b) Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors. Neurosci Biobehav Rev 35(3):804–817. doi:10.1016/j.neubiorev.2010.10.001
Berk M, Berk L, Udina M, Moylan S, Stafford L, Hallam K, Goldstone S, McGorry PD (2012) Palliative models of care for later stages of mental disorder: maximizing recovery, maintaining hope, and building morale. Aust N Z J Psychiatry 46(2):92–99. doi:10.1177/0004867411432072
Berk M, Berk L, Dodd S, Cotton S, Macneil C, Daglas R, Conus P, Bechdolf A, Moylan S, Malhi GS (2014) Stage managing bipolar disorder. Bipolar Disord 16(5):471–477. doi:10.1111/bdi.12099
Blumberg HP, Krystal JH, Bansal R, Martin A, Dziura J, Durkin K, Martin L, Gerard E, Charney DS, Peterson BS (2006) Age, rapid-cycling, and pharmacotherapy effects on ventral prefrontal cortex in bipolar disorder: a cross-sectional study. Biol Psychiatry 59(7):611–618. doi:10.1016/j.biopsych.2005.08.031
Bora E, Fornito A, Yucel M, Pantelis C (2010) Voxelwise meta-analysis of gray matter abnormalities in bipolar disorder. Biol Psychiatry 67(11):1097–1105. doi:10.1016/j.biopsych.2010.01.020
Brietzke E, Kapczinski F (2008) TNF-alpha as a molecular target in bipolar disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 32(6):1355–1361. doi:10.1016/j.pnpbp.2008.01.006
Brietzke E, Stertz L, Fernandes BS, Kauer-Sant’anna M, Mascarenhas M, Escosteguy Vargas A, Chies JA, Kapczinski F (2009) Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J Affect Disord 116(3):214–217. doi:10.1016/j.jad.2008.12.001
Carlson GA, Goodwin FK (1973) The stages of mania. A longitudinal analysis of the manic episode. Arch Gen Psychiatry 28(2):221–228
Carvalho AF, Dimellis D, Gonda X, Vieta E, McLntyre RS, Fountoulakis KN (2014) Rapid cycling in bipolar disorder: a systematic review. J Clin Psychiatry 75(6):e578–e586. doi:10.4088/JCP.13r08905
Cavanagh JT, Van Beck M, Muir W, Blackwood DH (2002) Case-control study of neurocognitive function in euthymic patients with bipolar disorder: an association with mania. Br J Psychiatry 180:320–326
Chang CC, Jou SH, Lin TT, Liu CS (2014) Mitochondrial DNA variation and increased oxidative damage in euthymic patients with bipolar disorder. Psychiatry Clin Neurosci 68(7):551–557. doi:10.1111/pcn.12163
Clark L, Iversen SD, Goodwin GM (2002) Sustained attention deficit in bipolar disorder. Br J Psychiatry 180:313–319
Cosci F, Fava GA (2013) Staging of mental disorders: systematic review. Psychother Psychosom 82(1):20–34. doi:10.1159/000342243
Cunha AB, Andreazza AC, Gomes FA, Frey BN, da Silveira LE, Goncalves CA, Kapczinski F (2008) Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder. Eur Arch Psychiatry Clin Neurosci 258(5):300–304. doi:10.1007/s00406-007-0797-0
Denicoff KD, Ali SO, Mirsky AF, Smith-Jackson EE, Leverich GS, Duncan CC, Connell EG, Post RM (1999) Relationship between prior course of illness and neuropsychological functioning in patients with bipolar disorder. J Affect Disord 56(1):67–73, S0165-0327(99)00028-2 [pii]
Duffy A, Alda M, Hajek T, Sherry SB, Grof P (2010) Early stages in the development of bipolar disorder. J Affect Disord 121(1–2):127–135. doi:10.1016/j.jad.2009.05.022
El-Badri SM, Ashton CH, Moore PB, Marsh VR, Ferrier IN (2001) Electrophysiological and cognitive function in young euthymic patients with bipolar affective disorder. Bipolar Disord 3(2):79–87
Fava GA (1999) Subclinical symptoms in mood disorders: pathophysiological and therapeutic implications. Psychol Med 29(1):47–61
Fava GA, Kellner R (1993) Staging: a neglected dimension in psychiatric classification. Acta Psychiatr Scand 87(4):225–230
Fernandes BS, Gama CS, Cereser KM, Yatham LN, Fries GR, Colpo G, de Lucena D, Kunz M, Gomes FA, Kapczinski F (2011) Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis. J Psychiatr Res 45(8):995–1004. doi:10.1016/j.jpsychires.2011.03.002
Fountoulakis KN (2009) An update of evidence-based treatment of bipolar depression: where do we stand? Curr Opin Psychiatry 23(1):19–24. doi:10.1097/YCO.0b013e328333e132
Fountoulakis KN (2012) Refractoriness in bipolar disorder: definitions and evidence-based treatment. CNS Neurosci Ther 18(3):227–237. doi:10.1111/j.1755-5949.2011.00259.x
Fountoulakis KN, Vieta E (2008) Treatment of bipolar disorder: a systematic review of available data and clinical perspectives. Int J Neuropsychopharmacol 11(7):999–1029. doi:10.1017/S1461145708009231, S1461145708009231 [pii]
Fountoulakis KN, Giannakopoulos P, Kovari E, Bouras C (2008a) Assessing the role of cingulate cortex in bipolar disorder: neuropathological, structural and functional imaging data. Brain Res Rev 59(1):9–21. doi:10.1016/j.brainresrev.2008.04.005
Fountoulakis KN, Grunze H, Panagiotidis P, Kaprinis G (2008b) Treatment of bipolar depression: an update. J Affect Disord 109(1-2):21–34. doi:10.1016/j.jad.2007.10.016, S0165-0327(07)00378-3 [pii]
Fountoulakis KN, Vieta E, Bouras C, Notaridis G, Giannakopoulos P, Kaprinis G, Akiskal H (2008c) A systematic review of existing data on long-term lithium therapy: neuroprotective or neurotoxic? Int J Neuropsychopharmacol 11(2):269–287. doi:10.1017/S1461145707007821
Fountoulakis KN, Kelsoe JR, Akiskal H (2011) Receptor targets for antidepressant therapy in bipolar disorder: an overview. J Affect Disord 138(3):222–238. doi:10.1016/j.jad.2011.04.043, S0165-0327(11)00210-2 [pii]
Frank E, Nimgaonkar VL, Phillips ML, Kupfer DJ (2014) All the world’s a (clinical) stage: rethinking bipolar disorder from a longitudinal perspective. Mol Psychiatry. doi:10.1038/mp.2014.71
Fries GR, Pfaffenseller B, Stertz L, Paz AV, Dargel AA, Kunz M, Kapczinski F (2012) Staging and neuroprogression in bipolar disorder. Curr Psychiatry Rep 14(6):667–675. doi:10.1007/s11920-012-0319-2
Garcia-Lopez A, De Dios-Perrino C, Ezquiaga E (2009) Polarity of the first episode and predominant polarity in a cohort of bipolar outpatients. Eur Neuropsychopharmacol 19:S571
Gelenberg AJ, Kane JM, Keller MB, Lavori P, Rosenbaum JF, Cole K, Lavelle J (1989) Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder. N Engl J Med 321(22):1489–1493. doi:10.1056/NEJM198911303212201
Goodwin F, Jamison K (2007) Manic-depressive illness, 2nd edn. Oxford University Press, New York
Grande I, Magalhaes PV, Chendo I, Stertz L, Panizutti B, Colpo GD, Rosa AR, Gama CS, Kapczinski F, Vieta E (2014) Staging bipolar disorder: clinical, biochemical, and functional correlates. Acta Psychiatr Scand 129(6):437–444. doi:10.1111/acps.12268
Hamilton BA, Naismith SL, Scott EM, Purcell S, Hickie IB (2011) Disability is already pronounced in young people with early stages of affective disorders: data from an early intervention service. J Affect Disord 131(1–3):84–91. doi:10.1016/j.jad.2010.10.052
Helms PM, Smith RE (1983) Recurrent psychotic depression. Evidence of diagnostic stability. J Affect Disord 5(1):51–54
Hickie IB, Scott J, Hermens DF, Scott EM, Naismith SL, Guastella AJ, Glozier N, McGorry PD (2013) Clinical classification in mental health at the cross-roads: which direction next? BMC Med 11:125. doi:10.1186/1741-7015-11-125
Insel TR (2010) Rethinking schizophrenia. Nature 468(7321):187–193. doi:10.1038/nature09552
Javadapour A, Malhi GS, Ivanovski B, Chen X, Wen W, Sachdev P (2007) Increased anterior cingulate cortex volume in bipolar I disorder. Aust N Z J Psychiatry 41(11):910–916. doi:10.1080/00048670701634978
Judd LL, Akiskal HS (2003) The prevalence and disability of bipolar spectrum disorders in the US population: re-analysis of the ECA database taking into account subthreshold cases. J Affect Disord 73(1–2):123–131
Judd LL, Akiskal HS, Schettler PJ, Endicott J, Maser J, Solomon DA, Leon AC, Rice JA, Keller MB (2002) The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 59(6):530–537, yoa20425 [pii]
Judd LL, Akiskal HS, Schettler PJ, Coryell W, Endicott J, Maser JD, Solomon DA, Leon AC, Keller MB (2003) A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 60(3):261–269, yoa20225 [pii]
Judd LL, Schettler PJ, Akiskal HS, Coryell W, Leon AC, Maser JD, Solomon DA (2008) Residual symptom recovery from major affective episodes in bipolar disorders and rapid episode relapse/recurrence. Arch Gen Psychiatry 65(4):386–394. doi:10.1001/archpsyc.65.4.386, 65/4/386 [pii]
Juster RP, McEwen BS, Lupien SJ (2010) Allostatic load biomarkers of chronic stress and impact on health and cognition. Neurosci Biobehav Rev 35(1):2–16. doi:10.1016/j.neubiorev.2009.10.002
Kapczinski F, Frey BN, Andreazza AC, Kauer-Sant’Anna M, Cunha AB, Post RM (2008a) Increased oxidative stress as a mechanism for decreased BDNF levels in acute manic episodes. Rev Bras Psiquiatr 30(3):243–245
Kapczinski F, Vieta E, Andreazza AC, Frey BN, Gomes FA, Tramontina J, Kauer-Sant’anna M, Grassi-Oliveira R, Post RM (2008b) Allostatic load in bipolar disorder: implications for pathophysiology and treatment. Neurosci Biobehav Rev 32(4):675–692. doi:10.1016/j.neubiorev.2007.10.005
Kapczinski F, Dias VV, Kauer-Sant’Anna M, Brietzke E, Vazquez GH, Vieta E, Berk M (2009a) The potential use of biomarkers as an adjunctive tool for staging bipolar disorder. Prog Neuro-Psychopharmacol Biol Psychiatry 33(8):1366–1371. doi:10.1016/j.pnpbp.2009.07.027
Kapczinski F, Dias VV, Kauer-Sant’Anna M, Frey BN, Grassi-Oliveira R, Colom F, Berk M (2009b) Clinical implications of a staging model for bipolar disorders. Expert Rev Neurother 9(7):957–966. doi:10.1586/ern.09.31
Kapczinski F, Dal-Pizzol F, Teixeira AL, Magalhaes PV, Kauer-Sant’Anna M, Klamt F, Pasquali MA, Quevedo J, Gama CS, Post R (2010) A systemic toxicity index developed to assess peripheral changes in mood episodes. Mol Psychiatry 15(8):784–786. doi:10.1038/mp.2009.112
Kapczinski F, Dal-Pizzol F, Teixeira AL, Magalhaes PV, Kauer-Sant’Anna M, Klamt F, Moreira JC, de Bittencourt Pasquali MA, Fries GR, Quevedo J, Gama CS, Post R (2011) Peripheral biomarkers and illness activity in bipolar disorder. J Psychiatr Res 45(2):156–161. doi:10.1016/j.jpsychires.2010.05.015
Kapczinski F, Magalhaes PV, Balanza-Martinez V, Dias VV, Frangou S, Gama CS, Gonzalez-Pinto A, Grande I, Ha K, Kauer-Sant’Anna M, Kunz M, Kupka R, Leboyer M, Lopez-Jaramillo C, Post RM, Rybakowski JK, Scott J, Strejilevitch S, Tohen M, Vazquez G, Yatham L, Vieta E, Berk M (2014) Staging systems in bipolar disorder: an International Society for Bipolar Disorders Task Force report. Acta Psychiatrica Scand. doi:10.1111/acps.12305
Kauer-Sant’Anna M, Kapczinski F, Andreazza AC, Bond DJ, Lam RW, Young LT, Yatham LN (2009) Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder. Int J Neuropsychopharmacol 12(4):447–458. doi:10.1017/S1461145708009310
Kendler KS, Thornton LM, Gardner CO (2000) Stressful life events and previous episodes in the etiology of major depression in women: an evaluation of the “kindling” hypothesis. Am J Psychiatry 157(8):1243–1251
Ketter TA, Houston JP, Adams DH, Risser RC, Meyers AL, Williamson DJ, Tohen M (2006) Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes. J Clin Psychiatry 67(1):95–101
Lagopoulos J, Hermens DF, Naismith SL, Scott EM, Hickie IB (2012) Frontal lobe changes occur early in the course of affective disorders in young people. BMC Psychiatry 12:4. doi:10.1186/1471-244X-12-4
Lebowitz BK, Shear PK, Steed MA, Strakowski SM (2001) Verbal fluency in mania: relationship to number of manic episodes. Neuropsychiatr Neuropsychol Behav Neurol 14(3):177–182
Lewandowski KE, Cohen BM, Ongur D (2011) Evolution of neuropsychological dysfunction during the course of schizophrenia and bipolar disorder. Psychol Med 41(2):225–241. doi:10.1017/S0033291710001042, S0033291710001042 [pii]
Lim CS, Baldessarini RJ, Vieta E, Yucel M, Bora E, Sim K (2013) Longitudinal neuroimaging and neuropsychological changes in bipolar disorder patients: review of the evidence. Neurosci Biobehav Rev 37(3):418–435. doi:10.1016/j.neubiorev.2013.01.003
Lin A, Reniers RL, Wood SJ (2013) Clinical staging in severe mental disorder: evidence from neurocognition and neuroimaging. Br J Psychiatry Suppl 54:s11–s17. doi:10.1192/bjp.bp.112.119156
Lopez-Jaramillo C, Lopera-Vasquez J, Gallo A, Ospina-Duque J, Bell V, Torrent C, Martinez-Aran A, Vieta E (2010) Effects of recurrence on the cognitive performance of patients with bipolar I disorder: implications for relapse prevention and treatment adherence. Bipolar Disord 12(5):557–567. doi:10.1111/j.1399-5618.2010.00835.x
Magalhaes PV, Jansen K, Pinheiro RT, Klamt F, Teixeira AL, da Silva RA, Kapczinski F (2011) Systemic toxicity in early-stage mood disorders. J Psychiatr Res 45(10):1407–1409. doi:10.1016/j.jpsychires.2011.05.008
Magalhaes PV, Dodd S, Nierenberg AA, Berk M (2012a) Cumulative morbidity and prognostic staging of illness in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). Aust N Z J Psychiatry 46(11):1058–1067. doi:10.1177/0004867412460593
Magalhaes PV, Jansen K, Pinheiro RT, Colpo GD, da Motta LL, Klamt F, da Silva RA, Kapczinski F (2012b) Peripheral oxidative damage in early-stage mood disorders: a nested population-based case-control study. Int J Neuropsychopharmacol 15(8):1043–1050. doi:10.1017/S1461145711001532
McGorry PD (2007) Issues for DSM-V: clinical staging: a heuristic pathway to valid nosology and safer, more effective treatment in psychiatry. Am J Psychiatry 164(6):859–860. doi:10.1176/appi.ajp.164.6.859
McGorry PD (2010a) Risk syndromes, clinical staging and DSM V: new diagnostic infrastructure for early intervention in psychiatry. Schizophr Res 120(1–3):49–53. doi:10.1016/j.schres.2010.03.016
McGorry PD (2010b) Staging in neuropsychiatry: a heuristic model for understanding, prevention and treatment. Neurotox Res 18(3–4):244–255. doi:10.1007/s12640-010-9179-x
McGorry PD, Hickie IB, Yung AR, Pantelis C, Jackson HJ (2006) Clinical staging of psychiatric disorders: a heuristic framework for choosing earlier, safer and more effective interventions. Aust N Z J Psychiatry 40(8):616–622. doi:10.1111/j.1440-1614.2006.01860.x
McGorry PD, Purcell R, Hickie IB, Yung AR, Pantelis C, Jackson HJ (2007) Clinical staging: a heuristic model for psychiatry and youth mental health. Med J Aust 187(7 Suppl):S40–S42
McGorry PD, Killackey E, Yung A (2008) Early intervention in psychosis: concepts, evidence and future directions. World Psychiatry 7(3):148–156
McGorry PD, Nelson B, Goldstone S, Yung AR (2010) Clinical staging: a heuristic and practical strategy for new research and better health and social outcomes for psychotic and related mood disorders. Can J Psychiatry 55(8):486–497
McIntyre RS, Correll C (2014) Predicting and preventing bipolar disorder: the need to fundamentally advance the strategic approach. Bipolar Disord 16(5):451–454. doi:10.1111/bdi.12216
McNamara RK, Nandagopal JJ, Strakowski SM, DelBello MP (2010) Preventative strategies for early-onset bipolar disorder: towards a clinical staging model. CNS Drugs 24(12):983–996. doi:10.2165/11539700-000000000-00000
Moore PB, Shepherd DJ, Eccleston D, Macmillan IC, Goswami U, McAllister VL, Ferrier IN (2001) Cerebral white matter lesions in bipolar affective disorder: relationship to outcome. Br J Psychiatry 178:172–176
Moorhead TW, McKirdy J, Sussmann JE, Hall J, Lawrie SM, Johnstone EC, McIntosh AM (2007) Progressive gray matter loss in patients with bipolar disorder. Biol Psychiatry 62(8):894–900. doi:10.1016/j.biopsych.2007.03.005
Munkholm K, Poulsen HE, Kessing LV, Vinberg M (2014) Elevated levels of urinary markers of oxidatively generated DNA and RNA damage in bipolar disorder. Bipolar Disord. doi:10.1111/bdi.12245
Nelson WH, Khan A, Orr WW Jr (1984) Delusional depression. Phenomenology, neuroendocrine function, and tricyclic antidepressant response. J Affect Disord 6(3–4):297–306
Nery FG, Chen HH, Hatch JP, Nicoletti MA, Brambilla P, Sassi RB, Mallinger AG, Keshavan MS, Soares JC (2009) Orbitofrontal cortex gray matter volumes in bipolar disorder patients: a region-of-interest MRI study. Bipolar Disord 11(2):145–153. doi:10.1111/j.1399-5618.2009.00662.x
Perry A, Tarrier N, Morriss R, McCarthy E, Limb K (1999) Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment. BMJ 318(7177):149–153
Popovic D, Vieta E (2013) Clinical implications of polarity index of drugs in maintenance treatment of bipolar disorder: a naturalistic study. Eur Neuropsychopharmacol 23:S68–S69
Post RM (1992) Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 149(8):999–1010
Post RM (2010) Mechanisms of illness progression in the recurrent affective disorders. Neurotox Res 18(3–4):256–271. doi:10.1007/s12640-010-9182-2
Post RM, Denicoff KD, Leverich GS, Altshuler LL, Frye MA, Suppes TM, Rush AJ, Keck PE Jr, McElroy SL, Luckenbaugh DA, Pollio C, Kupka R, Nolen WA (2003) Morbidity in 258 bipolar outpatients followed for 1 year with daily prospective ratings on the NIMH life chart method. J Clin Psychiatry 64(6):680–690; quiz 738–789
Post RM, Altshuler LL, Frye MA, Suppes T, Keck PE Jr, McElroy SL, Leverich GS, Luckenbaugh DA, Rowe M, Pizzarello S, Kupka RW, Grunze H, Nolen WA (2010) Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder. J Clin Psychiatry 71(9):1176–1186. doi:10.4088/JCP.08m04811yel; quiz 1252–1273
Post RM, Fleming J, Kapczinski F (2012) Neurobiological correlates of illness progression in the recurrent affective disorders. J Psychiatr Res 46(5):561–573. doi:10.1016/j.jpsychires.2012.02.004
Ranjekar PK, Hinge A, Hegde MV, Ghate M, Kale A, Sitasawad S, Wagh UV, Debsikdar VB, Mahadik SP (2003) Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Res 121(2):109–122
Reinares M, Colom F, Rosa AR, Bonnin CM, Franco C, Sole B, Kapczinski F, Vieta E (2010) The impact of staging bipolar disorder on treatment outcome of family psychoeducation. J Affect Disord 123(1–3):81–86. doi:10.1016/j.jad.2009.09.009
Reinares M, Papachristou E, Harvey P, Mar Bonnin C, Sanchez-Moreno J, Torrent C, Ayuso-Mateos JL, Ploubidis GB, Vieta E, Frangou S (2013) Towards a clinical staging for bipolar disorder: defining patient subtypes based on functional outcome. J Affect Disord 144(1–2):65–71. doi:10.1016/j.jad.2012.06.005
Robinson LJ, Ferrier IN (2006) Evolution of cognitive impairment in bipolar disorder: a systematic review of cross-sectional evidence. Bipolar Disord 8(2):103–116. doi:10.1111/j.1399-5618.2006.00277.x, BDI277 [pii]
Rosa AR, Frey BN, Andreazza AC, Cereser KM, Cunha AB, Quevedo J, Santin A, Gottfried C, Goncalves CA, Vieta E, Kapczinski F (2006) Increased serum glial cell line-derived neurotrophic factor immunocontent during manic and depressive episodes in individuals with bipolar disorder. Neurosci Lett 407(2):146–150. doi:10.1016/j.neulet.2006.08.026
Rosa AR, Gonzalez-Ortega I, Gonzalez-Pinto A, Echeburua E, Comes M, Martinez-Aran A, Ugarte A, Fernandez M, Vieta E (2012) One-year psychosocial functioning in patients in the early vs. late stage of bipolar disorder. Acta Psychiatr Scand 125(4):335–341. doi:10.1111/j.1600-0447.2011.01830.x
Rosa AR, Magalhaes PV, Czepielewski L, Sulzbach MV, Goi PD, Vieta E, Gama CS, Kapczinski F (2014) Clinical staging in bipolar disorder: focus on cognition and functioning. J Clin Psychiatry 75(5):e450–e456. doi:10.4088/JCP.13m08625
Scott J, Paykel E, Morriss R, Bentall R, Kinderman P, Johnson T, Abbott R, Hayhurst H (2006) Cognitive-behavioural therapy for severe and recurrent bipolar disorders: randomised controlled trial. Br J Psychiatry 188:313–320. doi:10.1192/bjp.188.4.313
Scott J, Leboyer M, Hickie I, Berk M, Kapczinski F, Frank E, Kupfer D, McGorry P (2013) Clinical staging in psychiatry: a cross-cutting model of diagnosis with heuristic and practical value. Br J Psychiatry 202(4):243–245. doi:10.1192/bjp.bp.112.110858
Segal ZV, Williams JM, Teasdale JD, Gemar M (1996) A cognitive science perspective on kindling and episode sensitization in recurrent affective disorder. Psychol Med 26(2):371–380
Silverstone T, McPherson H, Li Q, Doyle T (2003) Deep white matter hyperintensities in patients with bipolar depression, unipolar depression and age-matched control subjects. Bipolar Disord 5(1):53–57
Simon NM, Smoller JW, McNamara KL, Maser RS, Zalta AK, Pollack MH, Nierenberg AA, Fava M, Wong KK (2006) Telomere shortening and mood disorders: preliminary support for a chronic stress model of accelerated aging. Biol Psychiatry 60(5):432–435. doi:10.1016/j.biopsych.2006.02.004
Soares JC, Kochunov P, Monkul ES, Nicoletti MA, Brambilla P, Sassi RB, Mallinger AG, Frank E, Kupfer DJ, Lancaster J, Fox P (2005) Structural brain changes in bipolar disorder using deformation field morphometry. Neuroreport 16(6):541–544
Strakowski SM, Wilson DR, Tohen M, Woods BT, Douglass AW, Stoll AL (1993) Structural brain abnormalities in first-episode mania. Biol Psychiatry 33(8–9):602–609
Strakowski SM, DelBello MP, Zimmerman ME, Getz GE, Mills NP, Ret J, Shear P, Adler CM (2002) Ventricular and periventricular structural volumes in first- versus multiple-episode bipolar disorder. Am J Psychiatry 159(11):1841–1847
Strejilevich SA, Martino DJ (2013) Cognitive function in adulthood and elderly euthymic bipolar patients: a comparison to test models of cognitive evolution. J Affect Disord 150(3):1188–1191. doi:10.1016/j.jad.2013.05.012
Swann AC, Bowden CL, Calabrese JR, Dilsaver SC, Morris DD (1999) Differential effect of number of previous episodes of affective disorder on response to lithium or divalproex in acute mania. Am J Psychiatry 156(8):1264–1266
Tohen M, Vieta E, Gonzalez-Pinto A, Reed C, Lin D, European Mania in Bipolar Longitudinal Evaluation of Medication Advisory B (2010) Baseline characteristics and outcomes in patients with first episode or multiple episodes of acute mania. J Clin Psychiatry 71(3):255–261. doi:10.4088/JCP.08m04580
Torrent C, Bonnin Cdel M, Martinez-Aran A, Valle J, Amann BL, Gonzalez-Pinto A, Crespo JM, Ibanez A, Garcia-Portilla MP, Tabares-Seisdedos R, Arango C, Colom F, Sole B, Pacchiarotti I, Rosa AR, Ayuso-Mateos JL, Anaya C, Fernandez P, Landin-Romero R, Alonso-Lana S, Ortiz-Gil J, Segura B, Barbeito S, Vega P, Fernandez M, Ugarte A, Subira M, Cerrillo E, Custal N, Menchon JM, Saiz-Ruiz J, Rodao JM, Isella S, Alegria A, Al-Halabi S, Bobes J, Galvan G, Saiz PA, Balanza-Martinez V, Selva G, Fuentes-Dura I, Correa P, Mayoral M, Chiclana G, Merchan-Naranjo J, Rapado-Castro M, Salamero M, Vieta E (2013) Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study. Am J Psychiatry 170(8):852–859. doi:10.1176/appi.ajp.2012.12070971
Torres IJ, DeFreitas VG, DeFreitas CM, Kauer-Sant’Anna M, Bond DJ, Honer WG, Lam RW, Yatham LN (2010) Neurocognitive functioning in patients with bipolar I disorder recently recovered from a first manic episode. J Clin Psychiatry 71(9):1234–1242. doi:10.4088/JCP.08m04997yel
Vieta E, Reinares M, Rosa AR (2011) Staging bipolar disorder. Neurotox Res 19(2):279–285. doi:10.1007/s12640-010-9197-8
Vieta E, Popovic D, Rosa AR, Sole B, Grande I, Frey BN, Martinez-Aran A, Sanchez-Moreno J, Balanza-Martinez V, Tabares-Seisdedos R, Kapczinski F (2013) The clinical implications of cognitive impairment and allostatic load in bipolar disorder. E Psychiatry 28(1):21–29. doi:10.1016/j.eurpsy.2011.11.007
Vita A, De Peri L, Sacchetti E (2009) Gray matter, white matter, brain, and intracranial volumes in first-episode bipolar disorder: a meta-analysis of magnetic resonance imaging studies. Bipolar Disord 11(8):807–814. doi:10.1111/j.1399-5618.2009.00759.x
Walz JC, Andreazza AC, Frey BN, Cacilhas AA, Cereser KM, Cunha AB, Weyne F, Stertz L, Santin A, Goncalves CA, Kapczinski F (2007) Serum neurotrophin-3 is increased during manic and depressive episodes in bipolar disorder. Neurosci Lett 415(1):87–89. doi:10.1016/j.neulet.2007.01.002
Walz JC, Magalhaes PV, Giglio LM, Cunha AB, Stertz L, Fries GR, Andreazza AC, Kapczinski F (2009) Increased serum neurotrophin-4/5 levels in bipolar disorder. J Psychiatr Res 43(7):721–723. doi:10.1016/j.jpsychires.2008.10.005
Yatham LN, Kapczinski F, Andreazza AC, Trevor Young L, Lam RW, Kauer-Sant’anna M (2009) Accelerated age-related decrease in brain-derived neurotrophic factor levels in bipolar disorder. Int J Neuropsychopharmacol 12(1):137–139. doi:10.1017/S1461145708009449
Yung AR, McGorry PD (1996) The prodromal phase of first-episode psychosis: past and current conceptualizations. Schizophr Bull 22(2):353–370
Yung AR, McGorry PD (2007) Prediction of psychosis: setting the stage. Br J Psychiatry Suppl 51:s1–s8. doi:10.1192/bjp.191.51.s1
Zubieta JK, Huguelet P, O’Neil RL, Giordani BJ (2001) Cognitive function in euthymic bipolar I disorder. Psychiatry Res 102(1):9–20, S0165-1781(01)00242-6 [pii]
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Fountoulakis, K.N. (2015). Staging of Bipolar Disorder. In: Bipolar Disorder. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-37216-2_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-37216-2_15
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-37215-5
Online ISBN: 978-3-642-37216-2
eBook Packages: MedicineMedicine (R0)